Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized vs IV Dexmedetomidine for Emergence Agitation
NCT05641376Unknown
- Sponsor
- Assiut University
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in Emergence agitation (EA) (2 arms), sponsored by Assiut University. Primary endpoint: Paediatric Anaesthesia Emergence Delirium scale at 60 minutes. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT05641376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641376.